Impact of tocilizumab on clinical outcomes in severe covid-19 patients and risk of secondary infecti...
Impact of tocilizumab on clinical outcomes in severe covid-19 patients and risk of secondary infection: A case-control study
About this item
Full title
Author / Creator
Publisher
Istanbul: Marmara University
Journal title
Language
English
Formats
Publication information
Publisher
Istanbul: Marmara University
Subjects
More information
Scope and Contents
Contents
Objective: This study aimed to identify the effect of tocilizumab (TCZ) on clinical outcomes in severe COVID-19 patients. Material and Methods: We included hospitalized COVID-19 patients with an initial WHO scale ≥4. We matched the patients with baseline characteristics by using propensity scores. Then, we selected patients with C-reactive protein...
Alternative Titles
Full title
Impact of tocilizumab on clinical outcomes in severe covid-19 patients and risk of secondary infection: A case-control study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2718714555
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2718714555
Other Identifiers
ISSN
1019-1941
E-ISSN
1309-9469
DOI
10.5472/marumj.942700
